Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Waves Stop Sign At Kratom Product Launch After Failed NDI Notification

Feb 27 2018

• By Malcolm Spicer

Related Content

DEA Proposal To Schedule Kratom Stirs Wave Of Opposition

Dec 08 2016

Kratom: All Questions On Pre-DSHEA Ingredient Evidence In One Package

Oct 16 2017

FDA's Kratom Campaign Turns To Firms Destroying Inventory, Recalling Products

Feb 21 2018

FDA's Opioid Label For Kratom Called Misbranding By Marketers

Feb 07 2018

Additional Topics

United States Dietary Supplements Regulation Safety Ingredients FDA Consumer

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window